Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade

Hypertension

Volumn 30, Issue 1, 1997, Pages 22-28

  Filep, János G ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood pressure; Endothelin; Nitric oxide; Plasma volume; Receptors

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; BOSENTAN; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; PLASMA VOLUME; PRIORITY JOURNAL; RAT;

EID: 0030750722     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.22     Document Type: Article

References (41)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84: 9265-9269.
4. DeNucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 1988;85:9797-9800.
5. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85:587-590.
6. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993;92:99-104.
7. Lüscher TF, Yang Z, von Segesser L, Stulz P, Boulanger C, Siebenmann R, Turina M, Bühler F. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res. 1990;66:1088-1094.
8. Ito S, Juncos LA, Nushiro N, Johnson CS, Carretero OA. Endothelium-derived relaxing factor modulates endothelin action in afferent arterioles. Hypertension. 1991;17:1052-1056.
9. Lerman A, Sandok EK, Hilderbrand FL, Burnett JC Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation. 1992;85:1894-1898.
10. Filep JG, Földes-Filep E, Rousseau A, Sirois P, Fournier A. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol. 1993;110: 1213-1221.
11. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol. 1992;262:H611-H615.
12. Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol. 1991;104: 797-804.
13. Zimmerman RS, Martinez AJ, Maymind M, Barbee RW. Effect of endothelin on plasma volume and albumin escape. Circ Res. 1992; 70:1027-1034.
14. Ando K, Hirata Y, Schichiri M, Emori T, Maruno F. Presence of immunoreactive endothelin in human plasma. FEBS Lett. 1989;245: 164-166.
15. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
16. Filep JG, Clozel M, Fournier A, Földes-Filep E. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. Br J Pharmacol. 1994;113:845-852.
17. Richard V, Hogie M, Clozel M, Löffler BM, Thuillez Ch. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995;91:771-775.
18. Qiu C, Engels K, Baylis C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol. 1995;6:1476-1481.
19. Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassai JM, Hirth G, Müller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
20. A receptor antagonist. J Pharmacol Exp Ther. 1993;264: 1040-1046.
21. Filep JG, Bodolay E, Sipka S, Gyimesi E, Csipö I, Szegedi G. Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease. Circulation. 1995;92: 2969-2974.
22. Pollock DM, Divish BJ, Opgenorth TJ. Stimulation of endogenous endothelin release in the anesthetized rat. J Cardiovasc Pharmacol. 1993;22(suppl 8):S295-S298.
23. Löffler BM, Jacot-Guillarmod H, Maire JP. Concentrations and ratios of immunoreactive big-endothelin-1 and endothelin-1 in human, rat and rabbit plasma. Biochem Int. 1992;27:755-761.
24. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin-1 and big endothelin-1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci USA. 1995;92:6344-6348.
25. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
26. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994;89:1203-1208.
27. Vierhapper H, Wagner O, Nowotny P, Waldhausl W. Effect of endothelin-1 in man. Circulation. 1990;81:1415-1418.
28. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1992;267: 16066-16068.
29. Taylor AE, Granger DN. Exchange of macromolecules across the microcirculation. In: Renken EM, Michel CC, eds. Handbook of Physiology, Section 2: The Cardiovascular System, Volume IV, Part 1. Bethesda, Md: American Physiological Society; 1984:467-520.
30. Erjefalt JS, Erjefalt I, Sundler F, Persson CGA. Mucosal nitric oxide may tonically suppress airways plasma exudation. Am J Respir Crit Care Med. 1994;150:227-232.
31. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol. 1991;261:F1033-F1037.
32. Denton KM, Anderson WP. Intrarenal haemodynamic and glomerular responses to inhibition of nitric oxide formation in rabbits. J Physiol (Lond). 1994;475:159-167.
33. Tsukimoto K, Mathieu-Costello D, Prediletto R, West JB. Structural basis of increased permeability of pulmonary capillaries with high transmural pressures. Am Rev Respir Dis. 1990;141:A297.
34. Grega, GJ, Adamski SW, Robbins DE. Physiological and pharmacological evidence for the regulation of permeability. Fed Proc. 1986;45:96-100.
35. Yang ZH, Bühler FR, Diderich D, Lüscher TF. Different effects of endothelin-1 on cAMP- and cGMP-mediated vascular relaxation in human arteries and veins. J Cardiovasc Pharmacol. 1989;13(suppl 5):S129-S133.
36. B-like receptors. Biochem Biophys Res Commun. 1992;186:100-106.
37. Arndt H, Russell JB, Kurose I, Kubes P, Granger DN. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology. 1993;105:675-680.
38. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN. Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circ Res. 1993;73:164-171.
39. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. Microvascular responses to inhibition of nitric oxide production: role of active oxidants. Circ Res. 1995;76:30-39.
40. López-Farré A, Riesco A, Espinosa G, Dígiuni E, Cernadas MR, Alvarez V, Montón M, Rivas F, Gallego MJ, Egido J, Casado S, Caramelo C. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation. 1993;88: 1166-1171.
41. Ishida K, Takeshige K, Minakami S. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem Biophys Res Commun. 1990;173:496-500.